Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -5 of 5
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
1.
Phase II Chemotherapy with Elliptinium in Patients with Refractory Metastatic Adenocarcinoma of the Stomach
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
15 to 75
GUMC-17983
NCI-V84-0029
2.
Phase II Chemotherapy with Ellipticinium Acetate in Patients with Recurrent or Extensive Small Cell and Stage III non-Small Cell Carcinoma of the Lung
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
under 71
EORTC-08822
3.
Phase II Chemotherapy with Hydroxymethylellipticinium for Recurrent or Metastatic Adenoid Cystic Carcinoma of the Head and Neck
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
75 and under
EORTC-24841
4.
Phase II Chemotherapy with Ellipticinium Acetate for Advanced Breast Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
under 70
EORTC-10804
5.
Phase I Trial of Ellipticinium Acetate for Inoperable Extensive Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Closed
no age specified
NCOG-0C821
Select All on One Page
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute